Published in J Biol Chem on June 25, 1986
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol Cell Biol (1988) 2.10
A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg (2001) 4.48
Analysis of the ribonucleic acid of murine leukemia virus. J Virol (1969) 4.32
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 2.16
Thoracic epidural anaesthesia for coronary artery bypass graft surgery. Effects on postoperative complications. Anaesthesia (1997) 2.04
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
Viral ribonucleic acid polymerase: chick-embryo cells infected with vesicular stomatitis virus or Rous-associated virus. Biochim Biophys Acta (1965) 1.71
Metabolic requirements for infection by Rous sarcoma virus. I. The transient requirement for DNA synthesis. Virology (1966) 1.69
Monitoring women at risk for preterm labor. N Engl J Med (1998) 1.68
Electron microscopic observations on the ribonucleic acid of murine leukemia virus. J Virol (1969) 1.67
Inhibitors of glycosylation reverse retroviral interference. Virology (1982) 1.64
Control of acute Zollinger-Ellison syndrome with intravenous omeprazole. Lancet (1982) 1.63
Studies on the fixation and development of cellular transformation by Rous sarcoma virus. Virology (1968) 1.57
Induction of mutations in an RNA tumour virus by an analogue of a DNA precursor. Nat New Biol (1971) 1.46
A change in growth potential of cells after conversion by Rous sarcoma virus. J Cell Physiol (1967) 1.45
Human population genetic structure and diversity inferred from polymorphic L1(LINE-1) and Alu insertions. Hum Hered (2006) 1.44
Characteristics of cores of avian leuko-sarcoma viruses. Virology (1970) 1.36
Accumulation of water during transformation of cells by an avian sarcoma virus. Cell (1974) 1.35
Production of virus by mammalian cells tranformed by Rous sarcoma and murine sarcoma viruses. J Virol (1968) 1.34
Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment. Virology (1970) 1.29
Transformation by murine sarcoma virus: fixation (deoxyribonucleic acid synthesis) and development. J Virol (1968) 1.28
The safety profile of De-Nol. Digestion (1987) 1.26
Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res (1968) 1.17
Adenosylhomocysteine hydrolase inhibitors: synthesis of 5'-deoxy-5'-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virus. Biochem Biophys Res Commun (1978) 1.15
Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1. AIDS Res Hum Retroviruses (1997) 1.12
The uptake of nucleosides by cells in culture. I. Inhibition by heterologous nucleosides. Biochim Biophys Acta (1969) 1.04
3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology (1978) 1.03
Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals. Adv Pharmacol (1995) 1.02
Identity by descent and DNA sequence variation of human SINE and LINE elements. Cytogenet Genome Res (2005) 1.00
Quantitation of intracellular membrane-bound enzymes and receptors in digitonin-permeabilized cells. Anal Biochem (1983) 1.00
Metabolic requirements for infection by Rous sarcoma virus. 3. The synthesis on viral DNA. Virology (1972) 0.98
Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob Agents Chemother (1997) 0.97
Electrophoretic determinations of hyaluronate produced by cells in culture. Biochim Biophys Acta (1972) 0.97
Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Res (1994) 0.97
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nat Med (1997) 0.96
Studies on the relationship between glycolysis and (Na+ + K+)-ATPase in cultured cells. Biochim Biophys Acta (1984) 0.95
Configurational variants of oncornavirus RNAs. J Virol (1976) 0.94
Screening of colorectal cancer. Dig Dis Sci (1986) 0.94
Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am J Obstet Gynecol (1991) 0.94
Acute gastroduodenal lesions related to severe sepsis. Surg Gynecol Obstet (1976) 0.93
A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamides. Bioorg Med Chem (1997) 0.93
Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93
Metabolic requirements for infection by Rous sarcoma virus. IV. Virus reproduction and cellular transformation without cellular division. Virology (1972) 0.93
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
The structure of the RNA of RNA-containing tumor viruses. Curr Top Microbiol Immunol (1970) 0.89
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor. J Pharmacol Exp Ther (1996) 0.89
Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Antimicrob Agents Chemother (1999) 0.89
[Comparative efficacy of omeprazole and cimetidine in the treatment of duodenal ulcer in the acute stage. A French multicenter, controlled therapeutic trial]. Gastroenterol Clin Biol (1987) 0.88
[Treatment of duodenal and gastric ulcer with cimetidine. A multicenter double-blind trial (author's transl)]. Gastroenterol Clin Biol (1977) 0.88
Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem (1994) 0.88
Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV. Antiviral Res (1995) 0.87
[Histological and cytological study of the tumoral and nontumoral endocrine pancreas in the Zollinger-Ellison syndrome]. Rev Int Hepatol (1966) 0.87
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. Leukemia (1995) 0.86
Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene. Antiviral Res (1996) 0.86
The uptake of nucleosides by cells in culture. II. Inhibition by 2-mercapto-1-(beta-4-pyridethyl)benzimidazole. Biochim Biophys Acta (1969) 0.86
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. Virology (1995) 0.85
[Collagenous colitis, IgA deficiency, Basedow's disease and atrophic gastritis]. Gastroenterol Clin Biol (1985) 0.85
The use of gallium scanning and determination of human chorionic gonadotropin to evaluate resorption of an abdominal placenta. Am J Obstet Gynecol (1983) 0.85
Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action. J Acquir Immune Defic Syndr (1992) 0.85
Evidence for a DNA replicative genome for RNA-containing tumor viruses. Proc Natl Acad Sci U S A (1970) 0.84
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program. J Nat Prod (2001) 0.83
Metabolic requirements for infection by Rous sarcoma virus. II. The participation of cellular DNA. Virology (1966) 0.83
Virus-induced transformation without cell division. Science (1973) 0.83
Neural crest cells: temperature-dependent transformation by Rous sarcoma virus. Cell Differ (1979) 0.81
[Rat bioassay with urine (PSU) for diagnosis and postoperative follow-up in Zollinger-Ellison syndrome (author's transl)]. Acta Gastroenterol Belg (1973) 0.81
Long-term effects of 60-Hz electric vs. magnetic fields on IL-1 and IL-2 activity in sheep. Bioelectromagnetics (2001) 0.80
A method for the propagation of large amounts of Rous sarcoma virus. Virology (1968) 0.80
Flagellar surface differentiation. Evidence for multiple sites involved in mating of Chlamydomonas reinhardi. Exp Cell Res (1978) 0.80
MC29 virus-coded protein occurs as monomers and dimers in transformed cells. J Virol (1985) 0.79
Maternal herpes infection complicated by prolonged premature rupture of membranes. Am J Perinatol (1985) 0.79
Sodium concentrations affect metabolite uptake and cellular metabolism. J Cell Physiol (1978) 0.79
Quantification of DNA binding to cell-surfaces by flow cytometry. J Immunol Methods (2000) 0.79
Polypeptide composition of cell membranes from chick embryo fibroblasts transformed by rous sarcoma virus. Biochim Biophys Acta (1975) 0.78
Enzyme induction in mammalian cells defective in 28S ribosomal RNA formation. Nature (1976) 0.78
Increased glucose uptake capacity of Rous-transformed cells and the relevance of deprivation derepression. Cancer Res (1981) 0.78
[Treatment of a case of acute hypercalcemia with furosemide]. Ann Med Interne (Paris) (1971) 0.78
Mass screening for colorectal cancer: statement of the European Group for Colorectal Cancer Screening. Eur J Cancer Prev (1995) 0.78
Uptake of exogenous metabolites by virus-transformed cells: changes induced by temperature and pH. Arch Biochem Biophys (1976) 0.78
Tunicamycin-sensitive glycoproteins involved in the mating of Chlamydomonas reinhardi. Exp Cell Res (1982) 0.78
Oncogenes and the mitogenic signal pathway. Important Adv Oncol (1989) 0.77
Transformation of cells by rous sarcoma virus: cytoplasmic vacuolization. J Cell Physiol (1976) 0.77
A new competition assay for the solubilized hepatic galactosyl receptor. Anal Biochem (1985) 0.76
Sodium and rubidium uptake in cells transformed by Rous sarcoma virus. J Cell Physiol (1981) 0.76
Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists. Dig Dis Sci (1986) 0.76
The efficiency of (Na+ + K+)-ATPase in tumorigenic cells. Biochim Biophys Acta (1983) 0.76
[Epigastric pain and regurgitation: descriptive epidemiology in a representative sample of the adult population of France]. Gastroenterol Clin Biol (1988) 0.75
Cytoplasmic vacuoles of Rous virus transformed cells are organelles involved in cation uptake. J Gen Virol (1978) 0.75
"In vitro" mucin biosynthesis by human gastric mucosa biopsies. Biomedicine (1975) 0.75
[Anorectal stenosis related to the taking of suppositories combining dextropropoxyphene and paracetamol (Di-Antalvic)]. Gastroenterol Clin Biol (1984) 0.75
[Letter: A measure immediately applicable to hospitalized alcoholic patients]. Nouv Presse Med (1976) 0.75
The surgical treatment of peptic ulcer disease. A physician's view. Dig Dis Sci (1985) 0.75
[Treatment of duodenal ulcer outbreak with omeprazole. Results of a multicenter non-controlled study]. Gastroenterol Clin Biol (1984) 0.75
[Evaluation by the PABA test of the effects of cimetidine combined with pancreatic extracts in severe pancreatic insufficiency]. Gastroenterol Clin Biol (1983) 0.75
[Good clinical practices. Point of view of the university hospital]. Rev Med Interne (1986) 0.75
Incorporation of radioactive proline and fucose in gastric mucosal biopsies. Correlation with histological findings. Clin Physiol Biochem (1984) 0.75